ICON Enhances Endpoint Adjudication Services for Clinical Trials

Jun 11, 2018
By Applied Clinical Trials Editors

ICON plc, a global provider of drug development and commercialization solutions and services, announced it has signed an agreement with AG Mednet to use Judi, a comprehensive electronic endpoint adjudication system, to manage workflow and ensure data quality for enhanced endpoint event adjudication services.

Read the full release here.

native1_300x100
lorem ipsum